# A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis

> **NCT00569101** · PHASE2 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 9 (estimated)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** tacrolimus

## Key facts

- **NCT ID:** NCT00569101
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-09
- **Primary completion:** —
- **Final completion:** 2008-03
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2007-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00569101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00569101, "A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00569101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*